Professional Services

DPEBB Professional Services Chart

This handy chart presents an overview of all current provincially funded services in Saskatchewan. You will find:

  • Descriptions,
  • Notes and limitations,
  • Service fees, and
  • PseudoDINS.

(Updated July 5, 2023) DPEBB Professional services chart with PseudoDins


Injection Services

 

Influenza Immunization Program 2022-2023

 

Policy and Bulletin Documents (DPEBB)

Pharmacy Registration 2022-2023

2022-2023 updates:

Sask Cancer Agency Influenza Immunization Guideline 2022

Saskatchewan Influenza Immunization Policy 2022-23

Influenza Immunization Program Vaccine Distribution 2022-23

Participating Pharmacies List 2022-2023

PAS It ON Influenza Immunization Program 2022-2023

For more information, click here.


Consent Form and Support Guide

Vaccine Screening and Consent Form (all vaccines)

Guide for Vaccine Screening and Consent Form: Pharmacy Use Only Note – Members may access this resource through their SHIRP account

Injectable Drug (non-vaccine) Screening Tool and Consent Form


PAS Support Tools

PAS 2022-2023 Influenza Immunization Program Webinar, click here.

2022-2023 Influenza Immunization Program Power Point Slides

Cold Chain Log – October 2016

Injection Supply Checklist – October 2020

Anaphylaxis Kit Record – October 2016


Other Injection Resources

CPDPP has recently created brand new training videos, including:

IM Injection – Landmarking Deltoid 

IM Injection – Full Process 

IM Injection – Landmarking Vastus Lateralis  

SUBQ Injection – Landmarking Outer Triceps 

Needle Length 

Withdrawal from Vial 

Child Hold Demonstration


Exposure Protocol

Needle Stick Injury Image

Management of Exposure to Blood and Body Fluids


Adverse Event Report

Adverse Events Following Immunization (AEFI) Reporting Form – Canada.ca


COVID-19 Immunization Program

COVID-19 Immunization Program


Direct Observed Therapy (DOT)

The Drug Plan and Extended Benefits Branch (DPEBB) will remunerate pharmacies for witnessing the administration of approved Hepatitis C medications to eligible patients. The purpose of this program is to optimize patient medication adherence by reducing the risk of treatment interruption for approved Hepatitis C medications.

DOT Policy 2017

#637 Pharmacy Information Bulletin April 2017.pdf

#645 Pharmacy Information Bulletin August 2017

#663 Pharmacy Information Bulletin April 2018

#165 Saskatchewan Formulary Bulletin April 2017.pdf

#170 Saskatchewan Formulary Bulletin April 2018 – Hepatitis C.pdf


Saskatchewan Medication Assessment Program (SMAP)

The Saskatchewan Medication Assessment Program or SMAP is a provincial program available to beneficiaries under the Drug Plan and Extended Benefits Branch (DPEBB) age 65 and older who are community-based, living in their own residence, taking five (5) or more chronic or taking an anticoagulant or taking a Beers List medication.

These patients may receive an annual medication assessment and if eligible and require, follow-ups and compliance packaging. Patients living in an approved private service home or group home are eligible for an annual medication assessment.

New Mandatory SMAP Documentation

The Ministry of Health recently announced changes to the Saskatchewan Medication Assessment Program (SMAP) documentation as noted in the #639 Pharmacy Information Bulletin – SMAP Documentation. These changes will become mandatory as of September 1, 2017. These new forms may be used effective immediately.  

You will be required to use the new forms (below) in order for your pharmacy to receive remuneration from the Drug Plan and Extended Benefits Branch (DPEBB) for conducting a medication assessment under SMAP. If you have your own forms, they must be approved by the DPEBB prior to use in order for the SMAP fees to be eligible for remuneration. All previously approved forms will need to be re-approved to ensure they meet the DPEBB’s current requirements of the program.

SMAP Policy 2017

2017 SMAP Documentation Forms Fillable

NEW SMAP Mandatory Documentation Forms (pdf format)


Pharmacist Guide to SMAP

The Pharmacist Guide to SMAP (the “Guide”) was developed by PAS and the staff at the Medication Assessment Centre (MAC) to support pharmacists and pharmacy students. The Guide showcases a stepwise approach to performing a medication assessment and demonstrates how the process can be applied to the new SMAP documentation forms (or any other medication assessment documentation).

Pharmacist Guide for SMAP


Updated Policy and Bulletins

#639 Pharmacy Information Bulletin May 2017

Please review the Medication Assessment Program Comparison Chart for eligibility.

Medication Assessment Program Comparison Chart

The SMAP Mandatory Documentation forms below may be used until August 31, 2017. These forms have been developed by PAS and CPhA (adapted from CPhA’s Pharmacheck Program) to fulfil the documentation requirements of the SMAP program.

Please Note:  Documentation other than the forms produced by PAS, must be approved by the Drug Plan to prevent audit clawback.

SASK_Step 5_Practitioner Communication letter


Medication Assessment & Compliance Packaging Program (MACPP)

Eligible Drug Plan Extended Benefits Branch (DPEBB) beneficiaries may receive an annual medication assessment and compliance packaging if they are:

  • receiving homecare or mental health services, living in their own homes or
  • any patients living in an approved Community Living Service Delivery Group Homes (CLSD)

Please note: Although specific documentation is not mandatory, pharmacists are encouraged to use SMAP documentation for consistency.

Please review the MA Program Comparison Chart for Eligibility.

Medication Assessment Program Comparison Chart

Mental Health – MACCP Policy

Home Care – MACCP Policy

Home Care-Mental Health Request Form

CLSD MACCP Policy

Program overview for eligible clients living in a Community Living Service Delivery (CLSD) licensed group home or approved private service home


Minor Ailment Prescribing

Minor Ailment prescribing is a Level 1 Activity. Pharmacists providing minor ailment services to patients must follow the most recent Minor Ailment Guidelines and Documentation developed by medSask. Updates to Guidelines can happen at any time so check back often or subscribe to medSask News to receive email notifications.

MINOR AILMENTS Policy June 2019

MINOR AILMENTS Policy October 2018

#678 Pharmacy Information Bulletin October 2018

Minor ailments expansion with the new agreement.

Birth Control FAQ – 2020

Bladder Infection FAQ – 2018

#590 Pharmacy Information Bulletin August 2015

#566 Pharmacy Information Bulletin April 2014

Pharmacists may bill the Drug Plan a Patient Assessment Fee for eligible patients in accordance with the Minor Ailments Policy

Special Edition Minor Ailments (52)

This PAS it On Special Edition provides an overview of all areas related to minor ailment prescribing. Published July 2011, updated January 2012.

Please note: All Saskatchewan residents with a valid health card (including NIHB, DVA or other federal beneficiaries) are eligible to receive this billable service funded by the provincial Drug Plan.

 


Prescriptive Authority (Level 1) Prescribing

All other Level 1 activities including: Interim Supplies, Unable to Access Supplies, Emergency Supply, Missing Information, Alter Dosage Form and Drug Reconciliation Activities Billing Policy are referenced in the Drug Plan’s series of Prescriptive Authority for Pharmacists Pharmacy Information Bulletins:

#767 Pharmacy Information Bulletin June 2021

Therapeutic Substitution Prescriptive Authority

#942 Pharmacy Information Bulletin March 2011

#493 Pharmacy Information Bulletin March 2011

FAQ

Published March 31, 2011

#504 Pharmacy Information Bulletin January 2012

Policy on Narcotics and medications that do not require a prescription

Published January 1, 2012

In addition to a Special Edition PAS It On Bulleting #48, PAS also created a Guide and an FAQ made available below to PAS members:

Level 1 Prescriptive Authority Pharmacist Guide

Published April 2011

Prescriptive Authority FAQs

PAS It On #48 – Special Edition Prescriptive Authority

Program Overview

#493 Pharmacy Information Bulletin March 2011

Please note:

Details pertaining to Minor Ailment Prescribing are outdated in the above documents. For updated information, please refer to the Minor Ailments section on this Professional Services page.

 


PACT is a tobacco cessation program available to beneficiaries of the provincial Drug Plan. It incorporates Prochaska’s “Stage of Change” theory and principles of Motivational Interviewing to support patients through their quit journey. Click here for more pharmacist and patient materials to support the delivery of the program. 

PAS in partnership with CPDPP and the SCA has updated PACT 1 & 2, the Oncology, and the Indigenous Tobacco training modules. The updated training modules are available on the CPDPP website. The updated training is free for all Saskatchewan pharmacists and pharmacy students. 

*Please note: certification is required for any PACT counseling that is Bronze Plus and up*

Mandatory Documentation

The PACT forms below have been developed by PAS to fulfill the documentation requirements of the PACT Policy and Procedure. All forms are mandatory if billing the Drug Plan.

Please note:

Documentation other than the forms produced by PAS must be approved by the Drug Plan to prevent audit clawback.

STEP 1 – Bronze-Bronze Plus

STEP 2 – Patient Assessment

Includes:

  • 2A – Cessation of Tobacco, and
  • 2B – Review of Patient’s Smoking/Tobacco Use

STEP 3 – Personalized Care Plan

STEP 4 – Practitioner Communication Letter

STEP 5 – Group Session Individual Consent and Registration

Billing Policy

The complete policy and procedure requirements of the program including beneficiaries, pseudoDINS, and program limitations can be found in the documents below.

All policy and procedure documents can also be found in the Bulletins page on the Drug Plan WEB page, accessible only in community pharmacies.

PACT Policy & Procedure

Published June 3, 2009
Updated October 1, 2013

#546 Pharmacy Information Bulletin September 2013

Published September 26, 2013

 


Seamless Care

Pharmacies may charge a fee when a pharmacist provides seamless care services to a patient who is transferred from an institution to a community setting, in accordance with the Drug Plan’s Seamless Care Policy

#416 Pharmacy Information Bulletin April 2007

Seamless Care Policy

Published April 2007

A Trial Policy Document – Appendix B


Trial Prescription Program (TPP)

A pharmacy may charge a fee to the Drug Plan when a patient is enrolled in the TPP for eligible drugs, and Trial Prescription Program Policy is followed.

Trial Prescription Program Policy

Published July 2007

A Trial Policy Document – Appendix B


Refusal To Dispense